Management of women with atypical ductal hyperplasia (ADH) diagnosed on needle core biopsy of a screen-detected breast lesion

Women with ADH are at increased risk of invasive breast cancer. This clinical advice from the BreastScreen Australia Clinical Advisory Committee (CAC) outlines recommended best practice on this issue.


Management of women with atypical ductal hyperplasia

We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.

Publication date:
Publication type:
Health sector

The CAC researched treatment guidelines for managing women with atypical lesions as part of the BreastScreen Australia screening program. This advice outlines their recommendation.

Help us improve

If you would like a response please use the enquiries form instead.